明克治疗公司（MiNK Therapeutics Inc.）总部设于特拉华州，已与B. Riley证券公司（B. Riley Securities, Inc.）达成一项新的市场发行销售协议。该协议于2025年7月15日正式签署，允许公司通过B. Riley证券公司作为销售代理，发行普通股，最高总发行金额达5000万美元。 这些交易依据明克治疗公司在2022年11月向美国证券交易委员会提交的注册声明执行。Latham & Watkins律师事务所为此协议提供专业法律意见。 协议细节体现了公司在资本市场的战略布局。B. Riley证券公司将全权处理股票销售事宜，确保交易符合监管要求。明克治疗公司此举旨在优化资金结构，推动业务发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.